Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Insomnia in Adults.

Morin1, Daley, Ouellet

  • 1Ècole de psychologie, Université Laval, Pavillon Félix-Antoine-Savard, Bureau 1648, Quebec G1K 7P4, Canada. Cmorin@psy.ulaval.ca

Current Treatment Options in Neurology
|December 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dragées of Iron, Manna, and Bismuth.

New York monthly review of medical and surgical science and Buffalo medical journal·2023
Same author

C.V.S., military insurance, pension and tuberculosis commission.

Revue medicale de la Suisse romande·2010
Same author

Amphoteric Character of 2-Vinyloxiranes: Synthetic Equivalents of beta,gamma-Unsaturated Aldehydes and a Vinylogous Enolate We thank Professor Batey and his group for providing the allyl and crotyltrifluoroborates. This work was supported by the National Science and Engineering Research Council (NSERC) and the University of Toronto. S.G.O. thanks NSERC for a post-graduate scholarship.

Angewandte Chemie (International ed. in English)·2000
Same author

Letter to the editor

Annals of surgery·2000
Same author

The multiperson use of non-syringe injection equipment and risk of hepatitis c infection in a cohort of young adult injection drug users, chicago 1997-1999.

Annals of epidemiology·2000
Same author

Charge effect in point projection images of carbon fibres

Journal of microscopy·2000
Same journal

Visual Impairment and Driving in Older Adults: A Narrative Review.

Current treatment options in neurology·2026
Same journal

Non-Cognitive Symptoms in Alzheimer's Disease and Their Likely Impact on Patient Outcomes. A Scoping Review.

Current treatment options in neurology·2026
Same journal

Update on the Treatment of Autonomic Disorders.

Current treatment options in neurology·2025
Same journal

Primary Progressive Aphasia Treatment: Current Treatment Options in Neurology Article Topic: Management of Primary Progressive Aphasia.

Current treatment options in neurology·2025
Same journal

Emerging Principles for Treating Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD).

Current treatment options in neurology·2025
Same journal

Diagnosis and Management of Progressive Corticobasal Syndrome.

Current treatment options in neurology·2025
See all related articles

Insomnia treatment varies by type: address underlying causes for secondary insomnia, use hypnotics for acute situations, and prioritize behavioral therapy for chronic insomnia, often combined with medication.

Area of Science:

  • Sleep Medicine
  • Psychiatry

Background:

  • Insomnia is a common condition with significant impacts on daily life and mental health.
  • It can manifest as a symptom or a distinct syndrome.
  • Untreated insomnia increases the risk of depression and reduces quality of life.

Purpose of the Study:

  • To outline current treatment strategies for insomnia.
  • To differentiate approaches based on insomnia classification (acute, chronic, secondary).
  • To highlight the role of pharmacologic and behavioral interventions.

Main Methods:

  • Review of established treatment guidelines for insomnia.
  • Categorization of insomnia based on etiology and duration.
  • Evaluation of pharmacologic and behavioral treatment options.

Related Experiment Videos

Main Results:

  • For secondary insomnia, treating the underlying condition is primary.
  • Acute insomnia may require hypnotic medication, with benzodiazepine-receptor agents preferred.
  • Chronic insomnia management centers on behavioral treatments, supplemented by hypnotics.

Conclusions:

  • Combined behavioral and pharmacologic therapy offers synergistic benefits for chronic insomnia.
  • Intermittent medication use can be effective for recurrent insomnia.
  • Tailoring treatment to the specific type of insomnia is crucial for effective management.